Thus, the implementation of new therapeutic approaches to prevent or counteract the obesity-associated inflammation and disrupted insulin signaling is encouraged, especially given that the world’s population is aging rapidly [25,26]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.